…
Beamtree Holdings Limited provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally. It operates through four segments: Diagnostic; Clinical Decision Support; Coding & Data Quality Assurance; and Knowledge Networks. The company offers Activity BarCoding, an on-premise solution that captures customized data across organizations to support various operations; Ainsoff Deterioration Index, an application that enables acuity monitoring across the whole organization; operational services in health and social services data analytics; and clinical coding, auditing, education and training services. It also provides PICQ, a quality assessment tool for clinically coded data; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; RippleDown Expert that provides treatment recommendations, real-time alerts, and advanced reflex and appropriate testing recommendations; and RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors. In addition, the company offers RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; and workforce wellbeing collaborative program. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. The company was founded in 1996 and is headquartered in North Sydney, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Beamtree Holdings Ltd is an Australian healthcare technology company that develops data and analytics software used by hospitals, health services and payers to support clinical coding, activity measurement and decision support. Long-term growth drivers include global digitisation of health records, rising demand for efficiency and value-based care, recurring SaaS contracts and international expansion which may benefit revenue visibility and scale.
Key investment risks include competitive and execution risks from international expansion, reliance on institutional and government contracts, regulatory and data-privacy exposure, and potential pressure from pricing or contract renewals.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -18.19M | -6.35M | -5.83M | -6.19M | -5.97M |
| Net income | -18.27M | -6.16M | -5.11M | -6.91M | -4.45M |
| Selling general administrative | - | 21.82M | 1.25M | 23.18M | 13.77M |
| Selling and marketing expenses | - | 2.38M | 1.95M | - | 0.94M |
| Gross profit | -0.74M | 28.60M | 4.89M | 1.75M | 19.09M |
| Reconciled depreciation | - | 5.52M | 5.44M | 4.89M | 3.62M |
| Ebit | - | -6.32M | -5.77M | -6.72M | -5.94M |
| Ebitda | -4.99M | -0.81M | -0.33M | -1.26M | -2.33M |
| Depreciation and amortization | - | 5.52M | 5.44M | - | 3.62M |
| Operating income | -4.99M | -6.23M | -0.61M | -6.13M | -5.94M |
| Other operating expenses | 34.18M | 34.83M | 28.21M | 1.42M | 27.78M |
| Interest expense | 0.24M | 0.17M | 0.06M | 0.03M | 0.03M |
| Tax provision | - | -0.19M | -0.72M | 0.72M | -1.52M |
| Interest income | - | 0.05M | 0.15M | 0.06M | 0.07M |
| Net interest income | - | -0.12M | 0.09M | -0.03M | -0.07M |
| Income tax expense | 0.09M | -0.19M | -0.72M | 0.72M | -1.52M |
| Total revenue | 29.19M | 28.60M | 27.60M | 22.79M | 19.09M |
| Total operating expenses | 4.25M | 34.83M | 5.50M | - | 27.78M |
| Cost of revenue | 29.93M | 23.69M | 22.71M | - | - |
| Total other income expense net | -13.20M | -0.12M | -5.22M | 21.58M | 2.79M |
| Net income from continuing ops | - | -6.16M | -5.11M | -6.91M | -4.45M |
| Net income applicable to common shares | - | -6.16M | -5.11M | -6.91M | -4.45M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 37.38M | 54.29M | 59.65M | 62.53M | 63.91M |
| Intangible assets | 6.39M | 10.92M | - | 14.75M | 16.57M |
| Other current assets | - | 0.12M | - | 0.33M | 0.03M |
| Total liab | 14.03M | 12.36M | 12.52M | 15.31M | 15.33M |
| Total stockholder equity | 23.35M | 41.93M | 47.14M | 47.22M | 48.58M |
| Other current liab | 8.69M | - | 4.02M | 8.30M | 7.83M |
| Common stock | 59.67M | - | 59.30M | 55.27M | 50.20M |
| Capital stock | - | 59.56M | - | 55.27M | 50.20M |
| Retained earnings | -38.27M | -20.00M | -13.88M | -9.18M | -2.27M |
| Other liab | - | - | - | 2.54M | 5.65M |
| Good will | 21.36M | 30.93M | 30.93M | 30.93M | 30.93M |
| Other assets | - | - | 0.00M | 1.88M | 2.19M |
| Cash | 2.51M | 4.78M | 5.04M | 8.81M | 6.35M |
| Cash and equivalents | - | - | - | 8.81M | 6.35M |
| Total current liabilities | 12.81M | 7.81M | 9.00M | 12.23M | 8.92M |
| Current deferred revenue | - | - | 4.05M | - | 5.03M |
| Net debt | 1.52M | - | -3.38M | - | -5.23M |
| Short term debt | 3.52M | - | 0.17M | 0.00M | 0.36M |
| Short long term debt total | 4.04M | - | 1.66M | - | 1.12M |
| Other stockholder equity | 61.62M | - | - | 1.13M | 0.65M |
| Property plant equipment | - | - | - | 0.52M | 0.96M |
| Total current assets | 7.99M | 9.61M | 11.52M | 14.44M | 13.25M |
| Net tangible assets | - | - | - | 1.54M | 1.07M |
| Short term investments | - | - | - | 0.73M | 0.65M |
| Net receivables | 5.48M | 3.36M | 6.48M | 4.91M | 6.87M |
| Long term debt | - | 2.31M | - | 0.54M | 0.54M |
| Accounts payable | 0.60M | 1.17M | 0.76M | 1.51M | 0.74M |
| Accumulated other comprehensive income | 1.95M | - | 1.71M | - | 0.65M |
| Non currrent assets other | - | - | 13.75M | - | - |
| Non current assets total | 29.39M | 44.68M | 48.13M | 48.09M | 50.65M |
| Capital lease obligations | - | 0.95M | - | 0.22M | 0.58M |
| Long term debt total | - | - | - | 0.54M | 0.76M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | -2.45M | -4.02M | -2.65M | -5.16M |
| Change to liabilities | - | - | - | 1.47M | 2.34M |
| Total cashflows from investing activities | -3.89M | -2.45M | -4.02M | -2.65M | -5.16M |
| Net borrowings | - | 1.78M | - | -0.36M | -0.53M |
| Total cash from financing activities | 0.69M | 1.58M | 0.75M | 4.34M | -0.29M |
| Change to operating activities | - | - | - | -0.33M | 0.35M |
| Net income | -18.27M | -6.16M | -5.11M | -6.91M | -4.45M |
| Change in cash | -2.27M | -0.26M | -3.77M | 2.46M | -7.77M |
| Begin period cash flow | 4.78M | 5.04M | 8.81M | 6.35M | 14.12M |
| End period cash flow | 2.51M | 4.78M | 5.04M | 8.81M | 6.35M |
| Total cash from operating activities | 0.93M | 0.61M | -0.49M | 0.77M | -2.32M |
| Issuance of capital stock | - | 0.07M | 0.99M | 4.70M | 0.24M |
| Depreciation | - | - | 5.44M | 1.94M | 2.06M |
| Other cashflows from investing activities | - | -2.29M | -3.96M | 0.00M | -2.65M |
| Change to account receivables | -0.57M | 1.47M | -0.82M | 1.57M | -2.15M |
| Sale purchase of stock | - | - | 0.99M | 4.70M | 0.24M |
| Other cashflows from financing activities | -0.28M | -0.27M | -0.25M | - | -0.53M |
| Change to netincome | - | - | - | 0.08M | -1.70M |
| Capital expenditures | 0.15M | 2.45M | 4.02M | 0.12M | 2.51M |
| Change in working capital | 1.22M | 1.23M | -0.51M | 0.84M | 0.73M |
| Stock based compensation | - | - | 1.25M | - | - |
| Other non cash items | 17.99M | -0.62M | -1.57M | - | - |
| Free cash flow | 0.78M | -1.84M | -4.51M | -1.88M | -2.51M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BMT Beamtree Holdings Ltd |
-0.00 3.00% |
0.10 | - | - | 1.01 | 1.26 | 1.06 | 120.85 |
| PME Pro Medicus Ltd |
1.15 0.71% |
162.15 | 64.69 | 89.29 | 65.34 | 37.37 | 63.47 | 81.35 |
| AYA ARTRYA Ltd |
-0.24 6.30% |
3.57 | - | - | 23230.33 | 8.10 | 20004.93 | 0.33 |
| CGS Cogstate Ltd |
-0.06 1.78% |
3.31 | 36.00 | 28.17 | 9.16 | 6.93 | 6.33 | 19.23 |
| EIQ Echoiq Ltd |
-0.05 8.47% |
0.54 | - | - | 5395.50 | 40.77 | 5059.22 | -8.27 |
Beamtree Holdings Limited provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally. It operates through four segments: Diagnostic; Clinical Decision Support; Coding & Data Quality Assurance; and Knowledge Networks. The company offers Activity BarCoding, an on-premise solution that captures customized data across organizations to support various operations; Ainsoff Deterioration Index, an application that enables acuity monitoring across the whole organization; operational services in health and social services data analytics; and clinical coding, auditing, education and training services. It also provides PICQ, a quality assessment tool for clinically coded data; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; RippleDown Expert that provides treatment recommendations, real-time alerts, and advanced reflex and appropriate testing recommendations; and RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors. In addition, the company offers RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; and workforce wellbeing collaborative program. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. The company was founded in 1996 and is headquartered in North Sydney, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Tim Kelsey | Chief Exec. Officer | NA |
| Mr. Mark McLellan | COO & CFO | NA |
| Mr. Stephen Morgan | Chief Technology Officer | NA |
| Mr. Michael Reakes | Gen. Mang. | NA |
| Ms. Cheryl McCullagh | Chief Product Officer | NA |
| Ms. Nicole Payne | Head of Coding Assistance & Data Quality | NA |
| Ms. Jennifer Nobbs | Head of International Advisory | NA |
| Ms. Victoria Hirst | Head of Knowledge Networks | NA |
| Ms. Belinda Cleminson | Company Sec. | NA |
| Mr. Paul Richard O'Connor | Exec. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.